Human-derived experimental materials are valuable in drug discovery research. In particular, patient-derived samples such as blood samples and iPS cells are thought to have a genetic predisposition to cause disease and, at least in part, some disease characteristics and are expected to be applied for elucidating the etiology and drug discovery research. In this session, examples of utilization of human-derived samples in preclinical neuroscience research in our companies will be introduced.